Complex visual hallucinations with retention of insight: four cases of Charles Bonnet syndrome

  • Vesna Tepšić Ostojić Military Medical Academy, Psychiatric Clinic, Belgrade, Serbia; University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
  • Zagorka Gojković Military Medical Academy, Psychiatric Clinic, Belgrade, Serbia
  • Bratislav Živić Military Medical Academy, Psychiatric Clinic, Belgrade, Serbia; University of Defence, Faculty of Medicine of the Military Medical Academy, Belgrade, Serbia
Keywords: charles bonnet syndrome, diagnosis, differential, hallucinations, vision disorders

Abstract


Introduction. Complex visual hallucinations with retention of insight due to visual impairment are key symptoms of Charles Bonnet syndrome. The syndrome is a standalone diagnosis in the International Classification of Diseases, 11th Revision. Nevertheless, in clinical praxis, it is often misdiagnosed as psychosis or early stages of dementia, and it goes underreported by patients because of the fear of being diagnosed with a mental illness. Case report. We presented four elderly patients, who were referred for psychiatric consultation due to visual hallucinations, with preserved insight, but with impaired vision. All four patients had complex, vivid, and colorful hallucinations consisting of realistic objects, people, animals, or scenery that tend to recur. Their emotional response and impact on quality of life differed, and psychopharmacotherapy was determined according to their psychological symptoms. Empathic explanation of the symptoms’ origin and reassurance of the absence of mental illness for patients and caregivers were of vital importance in all cases. Conclusion. With the aging of the population, the number of patients with impaired vision also increases, and the importance of a multidisciplinary approach in the diagnostic procedures and treatment of Charles Bonnet syndrome is emphasized. Increased awareness of clinical characteristics and therapeutic approaches is required among all physicians who are in contact with elderly and/or impaired vision patients.

References

Hedges TR Jr. Charles Bonnet, his life, and his syndrome. Surv Ophthalmol 2007; 52(1): 111–4.

Vukicevic M, Fitzmaurice K. Butterflies and black lacy pat-terns: the prevalence and characteristics of Charles Bonnet hallucinations in an Australian population. Clin Exp Ophthalmol 2008; 36(7): 659–65.

Jan T, Del Castillo J. Visual hallucinations: Charles Bonnet syndrome. West J Emerg Med 2012; 13(6): 544‒7.

Jones L, Ditzel-Finn L, Enoch J, Moosajee M. An overview of psychological and social factors in Charles Bonnet syn-drome. Ther Adv Ophthalmol 2021; 13: 25158414211034715.

Doeller B, Kratochwil M, Sifari L, Hirnschall N, Findl O. Ben-efit of psychiatric evaluation on anxiety in patients with Charles Bonnet syndrome. BMJ Open Ophthalmol 2021; 6(1): e000463.

Pang L. Hallucinations Experienced by Visually Impaired: Charles Bonnet Syndrome. Optom Vis Sci 2016; 93(12): 1466‒78.

World Health Organization (WHO). International Classifica-tion of Diseases, 11th Revision (ICD-11) [Internet]. 2022 [accessed on 2023 July 14]. Available from: https://icd.who.int/browse11/l-m/en

Ffytche DH. Visual hallucinations and the Charles Bonnet syndrome. Curr Psychiatry Rep 2005; 7(3): 168‒79.

Donovan NJ, Blazer D. Social Isolation and Loneliness in Older Adults: Review and Commentary of a National Academies Report. Am J Geriatr Psychiatry 2020; 28(12): 1233‒44.

Le JT, Peprah D, Agrón E, Keenan TD, Clemons TE, Chew EY, et al. Associations between Age-Related Eye Diseases and Charles Bonnet Syndrome in Participants of the Age-Related Eye Disease Study 2: Report Number 26. Oph-thalmology 2022; 129(2): 233‒5.

Singh A, Subhi Y, Sørensen TL. Low awareness of the Charles Bonnet syndrome in patients attending a retinal clinic. Dan Med J 2014; 61(2): A4770.

Teunisse RJ, Cruysberg JR, Hoefnagels WH, Verbeek AL, Zitman FG. Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome. Lancet 1996; 347(9004): 794‒7.

Scott IU, Schein OD, Feuer WJ, Folstein MF. Visual halluci-nations in patients with retinal disease. Am J Ophthalmol 2001; 131(5): 590‒8.

Adachi N, Watanabe T, Matsuda H, Onuma T. Hyperperfu-sion in the lateral temporal cortex, the striatum and the thalamus during complex visual hallucinations: single photon emission computed tomography findings in pa-tients with Charles Bonnet syndrome. Psychiatry Clin Neurosci 2000; 54(2): 157‒62.

Cox TM, Ffytche DH. Negative outcome Charles Bonnet syndrome. Br J Ophthalmol 2014; 98(9): 1236‒9.

Rojas LC, Gurnani B. Charles Bonnet Syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Pub-lishing; 2022 [updated 2022 Dec 6; cited on 2023 Jan]. Available from: https://www.ncbi.nlm.nih.gov/books/NB

K585133/

Doane J, Stults B. Visual hallucinations related to angioten-sin-converting enzyme inhibitor use: case reports and re-view. J Clin Hypertens (Greenwich) 2013; 15(4): 230‒3.

Alao AO, Hanrahan B. Charles Bonnet syndrome: visual hallucination and multiple sclerosis. Int J Psychiatry Med 2003; 33(2): 195‒9.

Holroyd S, Rabins PV. A three-year follow-up study of vis-ual hallucinations in patients with macular degeneration. J Nerv Ment Dis 1996; 184(3): 188‒9.

Published
2023/11/02
Section
Case report